Table 4.

Multi-Level Adjusted Associations Between Select Social Area Attributes and All Cancer Outcomes (N=93,332)

				ZCTA-Level Attributes
Breast Outcomes	% Black	95% CI	Disadvantage	95% CI	Ethnic Isolation	95% CI	% College-Educated	95% CI
Stage local vs. regional/metastatic	1.00	1.00-1.00	0.97	0.93-1.01	0.95*	0.93-0.98	1.02*	1.00-1.04
Stage regional vs. metastatic	1.00	1.00-1.00	0.99	0.92-1.07	0.99	0.94-1.04	1.05*	1.02-1.08
Local Control	1.00	1.00-1.00	0.88*	0.81-0.94	1.01	0.96-1.07	0.93*	0.90-0.95
Adjuvant Chemotherapy	1.00	1.00-1.01	0.83*	0.73-0.94	1.05	0.97-1.14	0.92*	0.88-0.96
Post-Operative Surveillance	1.00	1.00-1.01	0.96	0.87-1.05	0.97	0.91-1.03	1.02	0.98-1.05
Five Year Survival	1.00	1.00-1.00	0.96	0.90-1.02	1.03	0.99-1.08	1.06	1.03-1.08
				ZCTA-Level Attributes
Colon Outcomes	% Black	95% CI	Disadvantage	95% CI	Ethnic Isolation	95% CI	% College-Educated	95% CI
Stage local vs. regional/metastatic	1.00*	1.00-1.01	0.93*	0.89-0.98	1.03*	1.00-1.07	1.02*	1.00-1.04
Stage regional vs. metastatic	1.00	1.00-1.00	0.97	0.91-1.02	1.00	0.96-1.04	1.00	0.98-1.03
Local Control	1.00	1.00-1.00	0.98	0.88-1.10	0.96	0.89-1.04	1.03	0.98-1.08
Adjuvant Chemotherapy	1.00	1.00-1.00	0.90	0.80-1.00	1.09*	1.01-1.18	0.96	0.92-1.01
Post-Operative Surveillance	1.00	0.99-1.00	1.00	0.89-1.12	0.97	0.90-1.05	0.99	0.95-1.04
Five Year Survival	1.00	1.00-1.00	0.98	0.92-1.05	1.04	1.00-1.09	1.06*	1.03-1.09
				ZCTA-Level Attributes
Rectal Outcomes	% Black	95% CI	Disadvantage	95% CI	Ethnic Isolation	95% CI	% College-Educated	95% CI
Stage local vs. regional/metastatic	1.00	1.00-1.00	0.97	0.89-1.05	0.97	0.92-1.02	1.03*	1.00-1.07
Stage regional vs. metastatic	1.00	1.00-1.01	0.86*	0.77-0.95	1.03	0.96-1.11	1.00	0.96-1.05
Local Control	1.00	0.99-1.00	0.96	0.84-1.10	1.17*	1.07-1.29	1.00	0.95-1.06
Adjuvant Chemotherapy	1.00	0.99-1.00	0.93	0.76-1.15	0.91	0.79-1.04	0.94	0.87-1.02
Post-Operative Surveillance	1.00	0.99-1.00	1.03	0.83-1.27	1.04	0.91-1.20	1.09*	1.01-1.18
Five Year Survival	1.00	0.99-1.00	1.04	0.91-1.18	0.97	0.89-1.05	1.09	1.04-1.15